Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Quest diagnostics incorporated symbols : ILMN save search
Next Generation Sequencing Services Markets, 2030 - Substantial Growth with Emphasis on Oncology and Reproductive Applications
Published: 2024-03-01 (Crawled : 19:00) - prnewswire.com
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
| Email alert
Add to watchlist
NVTA | $0.019 0.0% 22M
|
Health Services
| Email alert
Add to watchlist
SQL | $6.5991 -29.23% 22K
|
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
services growth
Clinical Biomarkers Market Analysis and Forecast, 2023-2033 - Cancer Biomarkers to Witness the Highest Growth between 2023 and 2033
Published: 2024-02-13 (Crawled : 03:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.99%
H: 0.88%
C: -0.52%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.01%
H: 0.55%
C: -1.66%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -1.32%
H: 0.37%
C: -1.83%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.04%
H: 0.72%
C: -1.81%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -2.03%
H: 1.0%
C: -0.44%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -1.64%
H: 0.58%
C: -0.56%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: -3.99%
H: 1.49%
C: -3.71%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -2.48%
H: 1.08%
C: -2.01%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 2.59%
H: 0.0%
C: -11.11%
cancer biomarkers growth market
Carrier Screening Market Worth $5.4 Billion | MarketsandMarkets™
Published: 2024-01-31 (Crawled : 15:30) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.67%
H: 0.48%
C: -4.32%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.46%
H: 0.41%
C: -0.76%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.53%
H: 0.0%
C: -2.31%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -0.2%
H: 2.4%
C: -3.7%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 0.0%
H: 4.95%
C: 0.99%
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: -0.76%
H: 2.2%
C: 0.67%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.49%
H: 1.17%
C: -2.37%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.86%
H: 0.0%
C: -0.43%
market
Global In-vitro Diagnostics Consumables Market Report 2023-2033: Infectious Disease, Oncology, and Cardiology Drive Rapid Growth in Consumables Market
Published: 2024-01-05 (Crawled : 03:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.28%
H: 1.02%
C: 0.73%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.44%
H: 1.22%
C: 0.54%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.78%
H: 0.21%
C: -0.25%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.45%
H: 0.85%
C: 0.11%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -2.54%
H: 4.66%
C: 1.87%
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
|
| O: -0.15%
H: 0.68%
C: 0.26%
report rapid global in-vitro diagnostics cardiology growth market
Global and Regional Next-Generation IVD Market Report 2023: Market Value to Surpass $150 Billion by 2033 - Rising Demand of POC Testing Boosting Growth Prospects
Published: 2023-10-20 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.68%
H: 1.33%
C: 0.05%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.16%
H: 0.88%
C: -0.13%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.49%
H: 0.43%
C: -0.27%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.0%
H: 0.92%
C: -0.7%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -0.15%
H: 0.74%
C: -1.5%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.03%
H: 1.58%
C: 0.42%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 0.26%
H: 0.96%
C: -0.28%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.16%
H: 0.88%
C: -0.13%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: 0.41%
H: 3.13%
C: 2.38%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.02%
H: 0.94%
C: -0.3%
report global poc growth market
United States Hereditary Genetic Testing Markets,2022-2032: Technological Advancements for Exome Sequencing/Rise of Direct-to-Consumer (DTC) Testing Services Leading to Multi-Billion Opportunities
Published: 2023-01-11 (Crawled : 12:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.54%
H: 2.41%
C: 2.0%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.24%
H: 0.6%
C: -0.04%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.96%
H: 2.74%
C: 2.65%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 2.36%
H: 9.68%
C: 9.68%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 2.16%
C: 1.89%
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: 0.66%
H: 9.53%
C: 8.55%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: 0.0%
H: 8.08%
C: 6.7%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 1.36%
H: 3.96%
C: 3.53%
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
|
| O: -0.03%
H: 2.44%
C: 2.11%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.68%
H: 11.09%
C: 11.07%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.02%
H: 1.04%
C: 1.04%
services genetic
Genomics Global Market to Reach $94.9 Billion by 2030 at a CAGR of 16.4%
Published: 2022-11-29 (Crawled : 20:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -0.34%
H: 2.24%
C: 2.24%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.25%
H: 1.72%
C: 1.6%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.01%
H: 5.56%
C: 5.56%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: 1.2%
H: 3.21%
C: 2.56%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.25%
H: 1.72%
C: 1.6%
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
|
| O: 0.11%
H: 13.95%
C: 13.64%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: 0.42%
H: 5.51%
C: 5.25%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.55%
H: 5.39%
C: 5.14%
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
|
| O: 0.2%
H: 10.5%
C: 10.27%
global genomics market
U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is expected to grow with a CAGR of 13.09% and reach $29.28 billion by 2032
Published: 2022-11-28 (Crawled : 15:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -0.13%
H: 0.69%
C: 0.14%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.38%
H: 0.3%
C: -0.87%
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: -0.82%
H: 1.64%
C: 0.64%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: -1.63%
H: 2.02%
C: -2.43%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.76%
H: 1.23%
C: -0.19%
genetic expected market
Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.43%
H: 2.47%
C: 1.85%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 2.35%
H: 2.94%
C: 2.21%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.4%
H: 13.31%
C: 13.31%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 1.38%
H: 3.62%
C: 3.49%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
VCYT | $19.43 1.2% 1.18% 1.4M
|
Health Technology
|
| O: 0.75%
H: 15.68%
C: 15.57%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 5.62%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -4.76%
H: 34.5%
C: 3.0%
genomic cancer
Quest Diagnostics Names Sam Samad Executive Vice President and Chief Financial Officer
Published: 2022-06-09 (Crawled : 21:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -1.79%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -4.29%
H: 0.12%
C: -4.96%
diagnostics diagnostic
Next-Generation Gynecological Cancer Diagnostics Market, 2031
Published: 2022-04-27 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -2.87%
H: 0.0%
C: 0.0%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -0.43%
H: 3.45%
C: 1.79%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -3.91%
H: 2.25%
C: 1.17%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -6.95%
H: 4.32%
C: -1.38%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -2.2%
H: 2.24%
C: -0.44%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.91%
H: 1.37%
C: 0.09%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: -6.64%
H: 1.78%
C: -1.42%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: -2.62%
H: 3.04%
C: 0.09%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -3.78%
H: 2.05%
C: -1.05%
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
|
| O: -3.5%
H: 3.75%
C: 0.29%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -2.84%
H: 1.46%
C: -1.17%
diagnostics cancer diagnostic
Carrier Screening Markets, 2031 - Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders
Published: 2022-03-11 (Crawled : 17:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.42%
H: 0.0%
C: 0.0%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.21%
H: 0.0%
C: 0.0%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -0.12%
H: 0.0%
C: 0.0%
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: -0.26%
H: 0.0%
C: 0.0%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: 0.95%
H: 0.0%
C: 0.0%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 1.34%
H: 0.0%
C: 0.0%
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
|
| O: 1.41%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -1.38%
H: 0.0%
C: 0.0%
genetic order
Global Precision Cardiology Markets to 2031 | A $3.58 Billion Opportunity Assessment with Insights on Emerging Opportunities and Leading Players & Their Offerings
Published: 2022-02-25 (Crawled : 20:00) - prnewswire.com
NVTA | $0.019 0.0% 22M
|
Health Services
| Email alert
Add to watchlist
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
OPK | $1.23 0.0% 2.7M
|
Health Technology
| Email alert
Add to watchlist
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
FLGT | $20.34 1.14% 1.13% 160K
|
Health Services
| Email alert
Add to watchlist
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
| Email alert
Add to watchlist
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
| Email alert
Add to watchlist
offering cardio cardiology
Organ Transplant Diagnostics Market, 2031 - Emergence of Nucleic Acid Amplification Testing (NAAT) & Growing Focus on Molecular HLA Typing
Published: 2021-11-25 (Crawled : 12:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
CDNA | $8.32 3.1% 3.0% 500K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
| Email alert
Add to watchlist
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
| Email alert
Add to watchlist
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
| Email alert
Add to watchlist
diagnostic test molecular growing diagnostics merge
Increasing Acceptance for Diagnostics of Socially Tabooed Health Conditions Underscores Growth in Genetic Testing Services Market, Valuation projected to touch Mark of US$ 78.3 Bn by 2027, Says TMR
Published: 2021-05-10 (Crawled : 16:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.58%
H: 2.18%
C: 1.24%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.59%
H: 0.33%
C: -0.97%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.27%
H: 0.09%
C: -0.64%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -5.33%
genetic test growth diagnostics diagnostic
Global Preimplantation Genetic Testing Industry (2020 to 2027) - Key Market Drivers and Trends
Published: 2021-04-26 (Crawled : 17:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.33%
H: 1.07%
C: 0.48%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.39%
H: 0.39%
C: -0.13%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -0.33%
H: 4.74%
C: 3.3%
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: 0.3%
H: 3.75%
C: 3.39%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.67%
H: 0.79%
C: 0.72%
genetic implant test
Worldwide Solid Tumor Testing Industry to 2030 - Technological Advancements in the Field of Cancer Genomics Present Opportunities
Published: 2021-04-16 (Crawled : 17:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: 0.77%
H: 0.33%
C: -0.02%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.61%
H: 0.74%
C: 0.73%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 0.47%
H: 0.94%
C: 0.6%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.0%
H: 0.08%
C: -3.64%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -0.01%
H: 0.51%
C: 0.22%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.36%
H: 0.17%
C: -0.03%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.61%
H: 0.74%
C: 0.73%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: -1.74%
H: 3.18%
C: 2.24%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.02%
H: 0.12%
C: -0.72%
test genomic cancer solid tumors
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.